Your session is about to expire
← Back to Search
Smoking Cessation Counseling + Pharmacotherapy for Smoking Cessation
Study Summary
This trial is for smokers who want to change their smoking behaviors and will offer counseling and potentially FDA approved smoking cessation drugs.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am 50 years old or older.I have smoked in the last 30 days and am open to treatments that could help me quit.I am medically cleared to use medications to help me stop smoking.You have an address and telephone number where he/she may be reached.I am not pregnant, breastfeeding, and if of childbearing potential, I am using effective birth control.I am willing and can have a low dose CT scan for lung cancer screening.You use tobacco products other than cigarettes or little cigars, like cigars, chewing tobacco, snuff, pipes, or e-cigarettes.I have smoked in the last 30 days and am open to treatments that could help me quit.I am currently using medication to help me quit smoking.I agree not to use any smoking cessation aids other than those provided by the study.I am willing and able to have a low dose CT scan for lung cancer screening.
- Group 1: Quitline (QL) Group
- Group 2: Quitline-Rx (QL-Rx) Group
- Group 3: Integrated Care (IC) Group
- All Individual Drugs Already Approved - Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
- Approved for 5 Other Conditions - This treatment demonstrated efficacy for 5 other conditions.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many test subjects are participating in the clinical trial?
"Unfortunately, this research is not looking for participants at the moment. Specifically, it was first posted on June 16th 2017 and most recently updated August 15th 2022. If you're interested in other studies there are 142 trials dedicated to smoking cessation and 71 questionnaires actively enrolling patients."
Is there evidence to suggest that Questionnaires have been employed in other scientific research?
"At the current moment, 71 research studies exploring Questionnaires are being conducted. Of these active trials, 5 of them have progressed to Phase 3. Conducting their investigations mostly from Green Bay, Wisconsin, there is a total of 204 locations running clinical trial for this experimental therapy."
Are there still vacancies for this clinical experiment?
"This clinical trial is not presently seeking participants, given the information available on clinicaltrials.gov. This study was first posted in June 2017 and last edited in August 2022; however, there are 213 other trials actively searching for patients right now."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
How responsive is this trial?
Typically responds via
Most responsive sites:
- University of Texas MD Anderson Cancer Center: < 48 hours
Average response time
- < 2 Days
Share this study with friends
Copy Link
Messenger